From the Journals

Vaccination status doesn’t impact infectivity timeline in kids


 

TOPLINE:

Half of kids with COVID-19 become noninfectious 3 days after testing positive, whether they were vaccinated or not, according to a new study. The findings indicate that return-to-school policies for infected children may not need to differ on the basis of vaccine or booster status.

METHODOLOGY:

  • The study looked at 76 children, both vaccinated and unvaccinated, aged 7-18 years who had tested positive for COVID-19.
  • Researchers performed nasal swabs every other day for 10 days, sending the swab to a lab to be tested for cytopathic effect (CPE), or cell death, an indicator of infectivity.
  • They took pictures of the lab cultures to look for signs of CPE starting at 6 days after the test, which corresponds to the 2nd day after testing positive.
  • If CPE characteristics were present in at least 30% of images, children were considered infectious.

TAKEAWAY:

  • By day 3, half of study participants were noninfectious, independent of whether they had been vaccinated.
  • By day 5, less than 25% of children were infectious, regardless of vaccination status.
  • Among vaccinated children, the duration of infectivity was similar for children who received a booster and for those who had not.
  • The authors state that these results are consistent with those of a study in adults with the Omicron variant, which found no association between vaccination status and infectivity duration.

IN PRACTICE:

“Our findings suggest that current policies requiring isolation for 5 days after a positive test might be appropriate, as the majority of children were not infectious by day 5. Additionally, return-to-school policies may not need to discriminate by vaccine or booster status,” the authors wrote.

SOURCE:

The study was led by Neeraj Sood, PhD, of the University of Southern California in Los Angeles, and was published in JAMA Pediatrics.

LIMITATIONS:

The sample size was small, and the authors identified the potential for nonresponse bias. The research did not include data from children who didn’t receive a test. CPE is the standard for estimating infectivity, but it can still carry inaccuracies.

DISCLOSURES:

The authors report no disclosures. The study was funded by RF Catalytic Capital.

A version of this article first appeared on Medscape.com.

Recommended Reading

COVID booster may transiently raise glucose levels in T1D
MDedge Infectious Disease
Paxlovid and Lagevrio benefit COVID outpatients in Omicron era
MDedge Infectious Disease
Creatine may improve key long COVID symptoms: Small study
MDedge Infectious Disease
Paxlovid weaker against current COVID-19 variants
MDedge Infectious Disease
Study: Antiviral med linked to COVID mutations that can spread
MDedge Infectious Disease
People with long COVID have specific blood biomarkers, study says
MDedge Infectious Disease
Study: Unexpected vaginal bleeding rises after COVID vaccination
MDedge Infectious Disease
COVID-19 virus infects coronary vasculature
MDedge Infectious Disease
Paxlovid tied to benefits in high-risk patients with COVID
MDedge Infectious Disease
COVID, no matter the severity, linked with urologic effects in men
MDedge Infectious Disease